| Name | Navivumab |
|---|
| Description | Navivumab (CT-P23) is an influenza A virus hemagglutinin HA monoclonal antibody. neutralizes H1, H2, H5, and H9 influenza A viruses by binding to the stem fusion domain in HA2[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |